Globally, women accounted for more than half of people living with HIV (53%) in 2022. In France, 54% of new infections were heterosexual in 2022, 71% of whom were born abroad, mainly in sub-Saharan Africa (74%). Among women, 80% of new cases were born abroad, of which at least 30% contracted HIV after arriving in France, often in connection with social vulnerability as shown by the French study Parcours. In the Paris region, 1,243 new cases among women were registered between 2018 and 2021 (about 300 per year).
Unstable housing, experiences of violence, lack of residence permits and sex trade increase the risk of HIV among women. Positive test migrants often report a higher frequency of forced sex. These women also face high risks of other STIs, unwanted pregnancies, violence and mental health problems.
PrEP is a means of preventing HIV infection by taking an antiretroviral drug, which has been fully proven to be effective in the form of tablets or injections. Pre-Exposure Prophylaxis (PrEP) is part of a comprehensive prevention service pathway.
Despite the free availability of PrEP in France from 2027 and essential monitoring tools for men and women at high risk, women at risk remain largely uncovered by prevention initiatives, making them a "hidden population" under-studied. In France, recent data show that only 5% of PrEP users are women, compared to 95% of men, mainly men who have sex with men (MSM).
Several factors hinder access to PrEP, including limited knowledge of available services, misperceptions of risk (because women rarely initiate sexual intercourse), fear of stigma and lack of resources. In addition, France lacks comprehensive programs that integrate health care, sexual health, mental health and social and legal support for these women.
The PrEVE study aims to demonstrate that the involvement of community-based organizations can play an important role in engaging and retaining women in vulnerable situations in a sexual health program. This program provides information, screening and prophylaxis to meet the specific sexual health needs of vulnerable women.
Female, 18 years of age or older
Living in Ile de France
Social/economic vulnerability (without personal residence or residence permit of less than 2 years or expiring in less than 1 year or without social security/AME/PUMA (ex CMU)
Sexual vulnerability: occasional paid sex worker
None
Single group
Rapid diagnostic orientation tests (TROD) HIV, Hepatitis, syphilis
Diagnostic testThe following information will be collected : * Socio-demographic characteristics * Lifestyle * Health status * Access to care and support in care * Life events/violence Knowledge of HIV prevention will be assessed It will be proposed to screen for potentially serious STIs in the absence of specific management. If one of these infections is detected, the women will be referred and accompanied to a specialized consultation in the medical centers participating in the study Women's needs in terms of health and access to care will be assessed: infections, gynecology, psychology, management of individual violence, sexual in particular, prophylaxis with regard to HIV
Number of women in vulnerable situations who accepted sexual health testing the HIV/Syphilis
Measure HIV/Syphilis assessed by rapid test using INSTI multiplex
Number of women in vulnerable situations who accepted sexual health testing the VHB
Measure VHB assessed by rapid test using TOYO Ag HBs/ac anti-HBS
Number of women in vulnerable situations who accepted sexual health testing the VHC
Measure VHC assessed by rapid test using INSTI HCV
Click on the lead sponsor to view all of their trials.
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Lead sponsor
Gilead Sciences
Collaborator
